Clinical trial
SHARE - Symbicort and Health Economics in a Real Life Evaluation
NCT00259766 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00259766 |
|---|---|
| Title | SHARE - Symbicort and Health Economics in a Real Life Evaluation |
| Official title | Symbicort and Health Economics in a Real Life Evaluation - SHARE - A Randomised, Open-Label, Parallel-Group, Multicentre Study to Assess the Asthma-Related Health-Care Costs, in Ordinary Clinical Practice During 12 Months |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Budesonide, Formoterol, Terbutaline |
| Enrollment | 1,970 |
| Start date | Apr 1, 2004 |
| Completion | May 1, 2007 |
| First posted | Dec 1, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Sweden |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: